Skip to content

Stent Thrombosis After Tandem Lesions Thrombectomy

PREDICTEURS ET IMPACT CLINIQUE DE LA THROMBOSE DU STENT APRES LES THROMBECTOMIES CEREBRALES POUR LES OCCLUSIONS EN TANDEM

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03588780
Acronym
DST-TANDEM
Enrollment
80
Registered
2018-07-17
Start date
2018-08-06
Completion date
2018-10-31
Last updated
2018-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Stroke With Large Vessel Occlusion

Keywords

acute stroke, thrombectomy, tandem lesions

Brief summary

The aim is to describe the rate of delayed stent thrombosis after endovascular management of consecutive tandem lesions, in a patient series with systematic follow-up of stent patency. In addition, Investigatros aim to research baseline patient characteristics that are associated with a higher risk of delayed stent thrombosis and to evaluate the clinical consequences of stent thrombosis

Interventions

None listed

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Patients who underwent endovascular treatments for acute ischemic stroke in Strasbourg University Hospitals between 01/01/2009 and 01/04/2018 * Association of extracranial internal carotid artery (ICA) occlusion or stenosis ≥70% using NASCET criteria and an intracranial arterial occlusion in the anterior circulation

Exclusion criteria

\- Endovascular treatments for complication of surgical carotid endarterectomy

Design outcomes

Primary

MeasureTime frame
Stent thrombosis rateparticipants will be followed for the duration of hospital stay, an expected average 15 days

Countries

France

Contacts

Primary ContactRémy BEAUJEUX, MD, PhD
remy.beaujeux@chru-strasbourg.fr33 3 88 12 78 71
Backup ContactRaoul POP, MD
raoul.pop@chru-strasbourg.fr33 3 88 12 78 71

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026